Other items potentially coming up are news regarding Rapport MSO, expansion of DME-IQ mso into new states, and whatever deal relating to that which was mentioned in December, a potential acquisition of checkpoint inhibitor and or neoantigen tech, an explanation of any relationship with Neon Therapeutics, and Scientus Pharma beginning work on buccal cannibus. The Mayo Clinic and Dr Knutson are listed in a graphic as partners, so is an older agreement towards a melonoma vaccine to begin again, or previous efforts for adoptive T cell tech to come into fruition? Tappimune was also mentioned as a partner? They actually have a new name now (Marker Therapeutics), but what’s that all about?